This work has been retracted.
Retraction Notice to: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing
Year: 2022
Type: retraction
Abstract: Main text(Molecular Therapy 28, 599–612, February 2020)Molecular Therapy is retracting this article. After receiving an email from one of the authors, evidence for image duplication in identical or altered fashion in Figures 2D, 3D, 4B, 4C, 4D, 8C, S2A, S2C, S3A, S3B, S3C, S4A, and S4C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction. Main text(Molecular Therapy 28, 599–612, February 2020)Molecular Therapy is retracting this article. After receiving an email from one of the authors, evidence for image duplication in identical or altered fashion in Figures 2D, 3D, 4B, 4C, 4D, 8C, S2A, S2C, S3A, S3B, S3C, S4A, and S4C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction. (Molecular Therapy 28, 599–612, February 2020) Molecular Therapy is retracting this article. After receiving an email from one of the authors, evidence for image duplication in identical or altered fashion in Figures 2D, 3D, 4B, 4C, 4D, 8C, S2A, S2C, S3A, S3B, S3C, S4A, and S4C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction. RETRACTED: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 ProcessingChen et al.Molecular TherapyNovember 20, 2019In BriefThis article has been retracted: please see Elsevier Policy on Article Withdrawal ( http://www.elsevier.com/locate/withdrawalpolicy ). Full-Text PDF Open Access
Source: Molecular Therapy
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,900
OpenAlex ID: W4281389944